News

BRAINTEASER: Interview with Pieter van Galen Patient advocate, European Multiple Sclerosis Platform (EMSP)

BRAINTEASER: Interview with Pieter van Galen Patient advocate, European Multiple Sclerosis Platform (EMSP)
Horizon 2020
Interviews

The use of technologies in the treatment and management of multiple sclerosis: the experience of Pieter van Galen, Patient advocate, European Multiple Sclerosis Platform (EMSP)

Pieter van Galen is from the Netherlands and studied Business & Management in Alkmaar. During his studies he travelled extensively doing various internships (Hungary, Spain, England and China). After his studies he started a training/consultancy company. He has now been living in Belgium for nearly 20 years and enjoys the international environment of Brussels. He was diagnosed with MS in 2006 and has been an active patient advocate, being a member of various steering groups related to multiple sclerosis and Big multiple sclerosis Data initiatives.

Watch the interview here:

NEWS​

Related News

Tackling obesity

8 Jul 2024
Apply for funding to develop effective strategies to tackle overweight and obesity. ‘Tackling obesity’ is open to applications submitted to the Popula...

Cancer research transatlantic development and skills enhancement award 2024

4 Jul 2024
Following the UK-US Cancer Summit, MRC and NIHR, in partnership with NCI, are launching a second competition for the cancer research transatlantic dev...

24/52 Liver Disease (EME Programme)

4 Jul 2024
The Efficacy and Mechanism Evaluation (EME) Programme is accepting Stage 1 applications to this funding opportunity.

24/50 Efficacy studies seeking to improve the health and wellbeing of women

4 Jul 2024
The Efficacy and Mechanism Evaluation (EME) Programme is accepting applications to their commissioned workstream.

Small Research Grants

4 Jul 2024
Throughout the year, we consider applications and allocate small amounts of funding for innovative research into neuroblastoma.

24/13 Digital Technology enabled interventions in Social Care commissioning brief

4 Jul 2024
The aim of the Health Technology Assessment (HTA) Programme is to ensure that high quality research information on the clinical effectiveness, cost-ef...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *